BioForce Nanosciences Holdings, Inc.
BFNH
$0.5279
$0.02444.85%
OTC PK
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 8.36% | 0.98% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 8.36% | 0.98% | |||
Operating Income | -8.36% | -0.98% | |||
Income Before Tax | -658.69% | -0.98% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -658.69% | -0.98% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -658.69% | -0.98% | |||
EBIT | -8.36% | -0.98% | |||
EBITDA | -- | -- | |||
EPS Basic | -590.48% | 0.00% | |||
Normalized Basic EPS | 0.00% | 0.00% | |||
EPS Diluted | -590.48% | 0.00% | |||
Normalized Diluted EPS | 0.00% | 0.00% | |||
Average Basic Shares Outstanding | 10.16% | 0.00% | |||
Average Diluted Shares Outstanding | 10.16% | 0.00% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |